Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-12

Clinical Trial Update: Effects of Palmitoylethanolamide on Inner Retinal Function in Glaucoma Patients by Pattern Electroretinogram [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing palmitoylethanolamide effects on inner retinal function in glaucoma patients using pattern electroretinogram, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Glaucoma | Phase 2 | Status: COMPLETED